Co-Authors
This is a "connection" page, showing publications co-authored by Franck Touret and Caroline Solas.
Connection Strength
0.467
-
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2. Antiviral Res. 2021 09; 193:105137.
Score: 0.239
-
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model. Nat Commun. 2021 03 19; 12(1):1735.
Score: 0.058
-
SARS-CoV-2 viral dynamics in non-human primates. PLoS Comput Biol. 2021 03; 17(3):e1008785.
Score: 0.058
-
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Nature. 2020 09; 585(7826):584-587.
Score: 0.056
-
Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2. Clin Pharmacol Ther. 2020 08; 108(2):188.
Score: 0.055